| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.26▲ | 5.28▲ | 5.31▼ | 5.10▲ | 5.36▼ |
| MA10 | 5.27▲ | 5.31▼ | 5.22▲ | 5.15▲ | 5.46▼ |
| MA20 | 5.28▲ | 5.19▲ | 5.12▲ | 5.40▼ | 5.67▼ |
| MA50 | 5.30▼ | 5.08▲ | 5.08▲ | 5.57▼ | 4.09▲ |
| MA100 | 5.23▲ | 5.08▲ | 5.22▲ | 5.53▼ | 3.86▲ |
| MA200 | 5.11▲ | 5.25▲ | 5.49▼ | 4.27▲ | 3.36▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.002▲ | 0.031▲ | -0.018▼ | -0.173▼ |
| RSI | 52.262▲ | 61.568▲ | 63.037▲ | 47.328▼ | 52.476▲ |
| STOCH | 31.232 | 54.694 | 89.845▲ | 28.931 | 26.304 |
| WILL %R | -35.294 | -19.178▲ | -12.963▲ | -54.369 | -74.317 |
| CCI | 31.700 | 3.421 | 60.332 | -20.509 | -125.378▼ |
|
Monday, March 23, 2026 05:00 AM
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) reported fourth-quarter and full-year 2025 financial results while advancing its MOLBREEVI program, including a filed Biologics License Application with the ...
|
|
Sunday, March 22, 2026 02:58 AM
LifeSci Capital analyst Francois Brisebois maintained a Buy rating on Savara today and set a price target of $11.00. According to TipRanks, Brisebois is a 2-star analyst with an average return of 0.1% ...
|
|
Sunday, March 15, 2026 01:00 AM
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) said the U.S. Food and Drug Administration does not plan to convene an advisory committee for its review of the MOLBREEVI biologics license ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/03/26 | 5.08 | 5.365 | 4.90 | 5.28 | 1,647,528 |
| 24/03/26 | 5.02 | 5.10 | 4.81 | 5.04 | 1,947,834 |
| 23/03/26 | 5.12 | 5.19 | 4.9492 | 5.08 | 1,952,867 |
| 20/03/26 | 5.14 | 5.185 | 4.905 | 4.96 | 9,317,313 |
| 19/03/26 | 5.02 | 5.20 | 4.88 | 5.16 | 2,279,727 |
| 18/03/26 | 5.12 | 5.125 | 4.95 | 5.04 | 1,900,360 |
| 17/03/26 | 5.25 | 5.26 | 5.085 | 5.15 | 2,141,199 |
| 16/03/26 | 5.32 | 5.38 | 5.10 | 5.23 | 2,319,067 |
| 13/03/26 | 5.32 | 5.51 | 5.12 | 5.25 | 2,224,830 |
| 12/03/26 | 5.41 | 5.485 | 5.14 | 5.32 | 1,061,368 |
|
|
||||
|
|
||||
|
|